Acorah Software Products - Accounts Production 19.4.351 false true 31 May 2025 1 June 2024 false true No description of principal activity 1 June 2025 31 May 2026 31 May 2026 14871975 Ms Katalin Britten iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14871975 2025-05-31 14871975 2026-05-31 14871975 2025-06-01 2026-05-31 14871975 frs-core:CurrentFinancialInstruments 2026-05-31 14871975 frs-bus:PrivateLimitedCompanyLtd 2025-06-01 2026-05-31 14871975 frs-bus:FilletedAccounts 2025-06-01 2026-05-31 14871975 frs-bus:Micro-entities 2025-06-01 2026-05-31 14871975 frs-bus:AuditExempt-NoAccountantsReport 2025-06-01 2026-05-31 14871975 frs-bus:Director1 2025-06-01 2026-05-31 14871975 2024-05-31 14871975 2025-05-31 14871975 2024-06-01 2025-05-31 14871975 frs-core:CurrentFinancialInstruments 2025-05-31
Registered number: 14871975
TRANCE FORMATION THERAPY LTD
Unaudited Financial Statements
For The Year Ended 31 May 2026
Balance Sheet
Registered number: 14871975
2026 2025
£ £
Current assets 73 35
Creditors: Amounts Falling Due Within One Year (644 ) (27 )
NET CURRENT ASSETS (LIABILITIES) (571 ) 8
TOTAL ASSETS LESS CURRENT LIABILITIES (571 ) 8
NET (LIABILITIES)/ASSETS (571 ) 8
CAPITAL AND RESERVES (571 ) 8

Notes

1. General Information
TRANCE FORMATION THERAPY LTD is a private company, limited by shares, incorporated in England & Wales, registered number 14871975 . The registered office is 128 City Road, London, EC1V 2NX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2025: 1)
1 1
For the year ending 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Ms Katalin Britten
Director
28/10/2026